Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuf Baran

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|April 2, 2011
Bioactive sphingolipids in response to chemotherapy: a scope on leukemiasHuseyin Atakan Ekiz, Yusuf Baran
International Journal of Cancer|May 27, 2010
Therapeutic applications of bioactive sphingolipids in hematological malignanciesHuseyin Atakan Ekiz, Yusuf Baran
Methods in Molecular Biology (Clifton, N.J.)|November 26, 2013
Use of microRNAs in personalized medicineCiğir Biray Avci, Yusuf Baran
Current Pharmaceutical Biotechnology|September 9, 2016
Cell Proliferation and Cytotoxicity AssaysAysun Adan, Yağmur Kiraz, Yusuf Baran
American Journal of Blood Research|September 3, 2013
Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor eraMelda Comert, Yusuf Baran, Guray Saydam
Technology in Cancer Research & Treatment|June 21, 2012
Macromolecular changes in nilotinib resistant K562 cells; an in vitro study by Fourier transform infrared spectroscopyCagatay Ceylan, Aylin Camgoz, Yusuf Baran
Advances in Experimental Medicine and Biology|October 29, 2024
Mesenchymal Stem Cells in Cancer TherapyZüleyha Baran, Melisa Çetinkaya, Yusuf Baran
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 19, 2015
T cells in tumor microenvironmentYağmur Kiraz, Yusuf Baran, Ayten Nalbant
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 26, 2013
The roles of macromolecules in imatinib resistance of chronic myeloid leukemia cells by Fourier transform infrared spectroscopyYusuf Baran, Cagatay Ceylan, Aylin Camgoz
Hematology (Amsterdam, Netherlands)|February 26, 2013
Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrestAysun Adan Gokbulut, Elif Apohan, Yusuf Baran
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Anti-Cancer Agents in Medicinal Chemistry|April 2, 2011
Bioactive sphingolipids in response to chemotherapy: a scope on leukemiasHuseyin Atakan Ekiz, Yusuf Baran
International Journal of Cancer|May 27, 2010
Therapeutic applications of bioactive sphingolipids in hematological malignanciesHuseyin Atakan Ekiz, Yusuf Baran
Methods in Molecular Biology (Clifton, N.J.)|November 26, 2013
Use of microRNAs in personalized medicineCiğir Biray Avci, Yusuf Baran
Current Pharmaceutical Biotechnology|September 9, 2016
Cell Proliferation and Cytotoxicity AssaysAysun Adan, Yağmur Kiraz, Yusuf Baran
American Journal of Blood Research|September 3, 2013
Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor eraMelda Comert, Yusuf Baran, Guray Saydam
Technology in Cancer Research & Treatment|June 21, 2012
Macromolecular changes in nilotinib resistant K562 cells; an in vitro study by Fourier transform infrared spectroscopyCagatay Ceylan, Aylin Camgoz, Yusuf Baran
Advances in Experimental Medicine and Biology|October 29, 2024
Mesenchymal Stem Cells in Cancer TherapyZüleyha Baran, Melisa Çetinkaya, Yusuf Baran
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 19, 2015
T cells in tumor microenvironmentYağmur Kiraz, Yusuf Baran, Ayten Nalbant
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 26, 2013
The roles of macromolecules in imatinib resistance of chronic myeloid leukemia cells by Fourier transform infrared spectroscopyYusuf Baran, Cagatay Ceylan, Aylin Camgoz
Hematology (Amsterdam, Netherlands)|February 26, 2013
Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrestAysun Adan Gokbulut, Elif Apohan, Yusuf Baran
Pageof 9